News and Announcements
Phylogica Achieves Research Milestone in PFIZER Collaboration
- Published May 31, 2012 11:23PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
PERTH, AUSTRALIA: May 31, 2012 – Phylogica Ltd (ASX: PYC, XETRA: PH7), a public Australian peptide drug discovery company, announced today that it has successfully achieved a research milestone under its Collaboration and License agreement with Pfizer to discover novel peptide-based vaccines. This milestone follows the successful completion of the first stage of the collaboration, which was announced in December 2010. Under the terms of the agreement, Phylogica will receive an undisclosed payment in relation to the recent milestone achievement.
Dr Paul Watt, Phylogica’s Chief Executive Officer, commented on the news: “We are excited to have reached this research milestone in our collaboration with Pfizer. Our Phylomer platform has unique capabilities to identify candidate antigens and we have identified multiple novel Phylomers that meet the criteria required for further evaluation by Pfizer. We look forward to the outcome of Pfizer’s ongoing evaluation of these Phylomers and hopefully advancing a candidate towards development.”
Company Updates
Dogs First to Reduce Risk: QBiotics’ Smarter Path to Oncology Markets
QBiotics took a compound derived from a north Queensland rainforest tree all the way to veterinary registration before pursuing human oncology to de-risk its human cancer programme. Interim CEO Ebru Davidson argues that sequence – now backed by early responses across several human cancers – is the company’s real asset. The story that pulled Wholesale […]
Built on discipline, not complexity: inside an ASX equities income strategy
Haydn Froggatt and Zac Brabin have decades of derivatives experience between them and access to almost any strategy in the market. They use two of the simplest structures available, and wrote 202 positions with them last year. Published by Fairway Capital Management. Based on an interview with co-founders Haydn Froggatt and Zac Brabin. Two traders, […]
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Backed By Leading Investment Groups and Family Offices
